2026 NPPES data Hematology & Oncology Physician NPI 1558339796 MD
Verify on CMS →

JORGE OTOYA, MD

Hematology & Oncology Physician in KISSIMMEE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 209 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
58%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$915.81
45 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JORGE OTOYA, MD filed 1,611 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in KISSIMMEE, Florida, prescribing 58% generic.

2K
Part D claims, 2023
58%
generic prescribing
$915.81
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JORGE OTOYA, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,611 Top 18% higher than 82% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). This entry sits in this band. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

JORGE OTOYA, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JORGE OTOYA, MD?

Quality data not reported

NPI registry status

Active

Issued 03/14/2006

NPI 1558339796

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

1,611 90% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Florida

How Hematology & Oncology Physician compares to other specialties among Florida providers

Florida providers

Hematology & Oncology Physician share within Florida

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JORGE OTOYA, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 737 WEST OAK STREET, KISSIMMEE, FL, 34741, with a listed phone of (407) 933-2775. NPI 1558339796 was issued on 03/14/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what OTOYA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,611 prescription claims written by this provider, covering 209 Medicare beneficiaries and totaling roughly $8.0 million in drug spend, split 42% brand-name and 58% generic by claim count, with an opioid prescribing rate of 6.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

737 WEST OAK STREET
KISSIMMEE, FL 34741

Provider Details

NPI 1558339796
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 03/14/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JORGE OTOYA, MD. Source: openpaymentsdata.cms.gov.

Total received

$916

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to JORGE OTOYA, MD. To verify JORGE OTOYA, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

JORGE OTOYA, MD — brand share 42.0%
Specialty average (est.)

42% brand-name claims vs 58% generic, on 1,611 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,611
Total Claims
$8.0M
Total Drug Cost
209
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,253
Total Day Supply
62,018
Brand vs Generic
42% brand / 58% generic
Brand Drug Cost
$7.5M
Generic Drug Cost
$511K
Opioid Claims
103 (6.4% rate)
Antibiotic Claims
18

Patient Demographics

Average Patient Age
74.0 years
Avg HCC Risk Score
3.05
Gender Split
66% female / 34% male
Age Distribution
<65: 27, 65-74: 80, 75-84: 81, 85+: 21

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JORGE OTOYA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
119
Dexamethasone
77
Revlimid
Lenalidomide
66
Exemestane
62
Ibrance
Palbociclib
58
Hydroxyurea
57
Tamoxifen Citrate
55
Imatinib Mesylate
52
Pomalyst
Pomalidomide
46
Cyclophosphamide
41

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How JORGE OTOYA, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

JORGE OTOYA, MD's 1,611 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as OTOYA.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JORGE OTOYA, MD's specialty?
JORGE OTOYA, MD specializes in Hematology & Oncology Physician and practices in KISSIMMEE, Florida. Credentials: MD.
How much does JORGE OTOYA, MD prescribe under Medicare Part D?
In 2023, JORGE OTOYA, MD wrote 1,611 Medicare Part D claims totaling $8.0M in drug costs for 209 beneficiaries.
Where is JORGE OTOYA, MD located?
JORGE OTOYA, MD is located at 737 WEST OAK STREET, KISSIMMEE, FL, 34741. Phone: (407) 933-2775.
What is JORGE OTOYA, MD's NPI number?
JORGE OTOYA, MD's National Provider Identifier (NPI) is 1558339796, issued on 03/14/2006.
Does JORGE OTOYA, MD prescribe more brand-name or generic drugs?
JORGE OTOYA, MD's prescribing is 42% brand-name and 58% generic drugs by claim count, with $7.5M in brand drug costs.
Does JORGE OTOYA, MD prescribe opioids?
Yes, JORGE OTOYA, MD had 103 opioid claims in 2023 with an opioid prescribing rate of 6.4%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does JORGE OTOYA, MD prescribe most often?
Based on 2023 Medicare Part D data, JORGE OTOYA, MD's most frequently prescribed drugs include Letrozole, Dexamethasone, Revlimid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JORGE OTOYA, MD accept Medicare?
JORGE OTOYA, MD appears in CMS Medicare data with 1,611 Part D claims and 209 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JORGE OTOYA, MD's credentials?
JORGE OTOYA, MD's NPI is 1558339796 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology